Kura Oncology (KURA) Tops Q2 EPS by 4c

Kura Oncology (NASDAQ: KURA) reported Q2 EPS of ($0.59), $0.04 better than the analyst estimate of ($0.63).

For earnings history and earnings-related data on Kura Oncology (KURA) click here.

You May Also Be Interested In

• BJ's Wholesale Club (BJ) Tops Q2 EPS by 19c, Beats on Revenue; Offers FY27 EPS Guidance
• Professional Diversity Network forms AI subsidiary with no assets yet
• Dollar stores see mixed outlook ahead of earnings next week, Gordon Haskett comments